From: Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes
Genotype | CVD- | CVD+ | ||
---|---|---|---|---|
T2DM- (n = 211) | T2DM+ (n = 247) | T2DM- (n = 232) | T2DM+ (n = 234) | |
E2/E2 | 1 (0.4%) | 2 (1.2%) | 1 (0.31%) | 1 (0.21%) |
E3/E3 | 160 (75.8%) | 183 (74.1%) | 144 (41.5%) | 139 (50.4%) |
E4/E4 | 1 (0.4%) | – | 6 (4.6%) | 4 (1.7%) |
E2/E3 | 24 (11.4%) | 16 (6.6%) | 23 (4.7%) | 20 (8.3%) |
E2/E4 | – | 3 (1.2%) | 12 (3.7%) | 7 (2.9%) |
E3/E4 | 25 (11.8%) | 43 (17.3%) | 46 (19.8%) | 63 (26.9%) |
p-value | 0.75 | 0.12 | 0.03 | 0.67 |